NCT00217711View on ClinicalTrials.gov

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

October 31, 2011

Conditions

Colorectal Cancer

Interventions

DRUG

Capecitabine

capecitabine

DRUG

irinotecan hydrochloride

DRUG

oxaliplatin

Trial Locations (4)

CH-7000

Kantonsspital Graubuenden, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-1011

Hirslanden Klinik Aarau, Lausanne

CH-8063

City Hospital Triemli, Zurich

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER

NCT00217711 - Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter